WASHINGTON D.C. – Today, the U.S. Court of Appeals for the DC Circuit ruled in favor of the U.S. Food and Drug Administration (FDA) in the case of Prohibition Juice v. FDA, upholding the agency’s marketing denial orders (MDOs) for the manufacturer’s flavored e-cigarette products. The FDA issued the MDOs after finding that having the products on the market was not in the interest of public health. ACS CAN filed an amicus curiae (or “friend of the court”) brief in support of the FDA in the case.
The American Cancer Society Cancer Action Network (ACS CAN) applauds the court’s decision, which requires Prohibition Juice to end all sales of their flavored e-cigarette products in U.S. markets. E-cigarette use has skyrocketed in recent years—particularly among young people—and poses major risks to users’ health and their susceptibility to cancer.
“The FDA was doing its job when it issued the MDOs to Prohibition Juice requiring it to remove dangerous e-cigarettes with flavors like Crazy Bubble Grape, and Green Apple Gummy Guts from shelves,” said Lisa Lacasse, president of ACS CAN. “With kid-friendly flavors, this industry is clearly targeting young people to lure them into a lifetime of addiction, a well-proven strategy of Big Tobacco for decades. Additionally, there is no evidence that flavors have any role in helping people who smoke traditional cigarettes quit. What research does show us is kids who use e-cigarettes are more likely to use combustible cigarettes and smoking remains the number one cause of cancer death.”
Flavored e-cigarette products pose a serious public health risk, especially to young people, and ACS CAN urges the FDA to continue reining in Big Tobacco and the proliferation of flavored e-cigarette products. By working with local, state and federal lawmakers, ACS CAN is working fervently to help end the sale of flavored e-cigarettes products across the country.